Advanced search
Publication Cover
Renal Failure Volume 45, 2023 - Issue 1
Submit an article Journal homepage
1,719
Views
1
CrossRef citations to date
0
Altmetric
Clinical Study

Exploration of the mechanism of NORAD activation of TGF-β1/Smad3 through miR-136-5p and promotion of tacrolimus-induced renal fibrosis

Lei Liua Department of Kidney Transplantation, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
,
Jia Guob Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
,
Xin-lu Panga Department of Kidney Transplantation, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
,
Wen-jun Shanga Department of Kidney Transplantation, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
,
Zhi-gang Wanga Department of Kidney Transplantation, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
,
Jun-xiang Wanga Department of Kidney Transplantation, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
,
Xian-lei Yang
&
Gui-wen Fenga Department of Kidney Transplantation, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaCorrespondence[email protected]
 show all
Article: 2147083 | Received 21 Jul 2022, Accepted 07 Nov 2022, Published online: 07 Feb 2023

References

  • Oberbauer R, Bestard O, Furian L, et al. Optimization of tacrolimus in kidney transplantation: new pharmacokinetic perspectives. Transplant Rev (Orlando). 2020;34(2):100531.
  • Wang D, Chen X, Fu M, et al. Tacrolimus increases the expression level of the chemokine receptor CXCR2 to promote renal fibrosis progression. Int J Mol Med. 2019;44(6):2181–2188.
  • Bennett J, Cassidy H, Slattery C, et al. Tacrolimus modulates TGF-beta signaling to induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells. JCM. 2016;5(5):50.
  • Liu L, Pang X, Shang W, et al. miR-136 improves renal fibrosis in diabetic rats by targeting down-regulation of tyrosine kinase SYK and inhibition of TGF-beta 1/Smad3 signaling pathway. Ren Fail. 2020;42(1):513–522.
  • Ma C, Yu Y, Lui Q, et al. Effect of miRNA on the TGF-beta/smad signal pathway in hepatic fibrosis. Chin J Clin Anat. 2021;39(3):369–372.
  • Noetel A, Kwiecinski M, Elfimova N, et al. microRNA are Central players in anti- and profibrotic gene regulation during liver fibrosis. Front Physiol. 2012;3:49.
  • Farooqi AA, Attar R, Qureshi MZ, et al. Interplay of long non-coding RNAs and TGF/SMAD signaling in different cancers. Cell Mol Biol (Noisy-le-grand). 2018;64(15):1–6.
  • Chung ACK, Huang XR, Zhou L, et al. Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice. Nephrol Dial Transplant. 2009;24(5):1443–1454.
  • Wang J-Y, Gao Y-B, Zhang N, et al. miR-21 overexpression enhances TGF-beta 1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. Mol Cell Endocrinol. 2014;392(1–2):163–172.
  • Lan HY. Diverse roles of TGF-beta/Smads in renal fibrosis and inflammation. Int J Biol Sci. 2011;7(7):1056–1067.
  • Feng M, Tang PM-K, Huang X-R, et al. TGF-beta mediates renal fibrosis via the Smad3-Erbb4-IR long noncoding RNA axis. Mol Ther. 2018;26(1):148–161.
  • Zhang Y-y, Tang PM-K, Tang PC-T, et al. LRNA9884, a novel Smad3-dependent long noncoding RNA, promotes diabetic kidney injury in db/db mice via enhancing MCP-1-dependent renal inflammation. Diabetes. 2019;68(7):1485–1498.
  • Ye T, Ye Z. LncRNA NORAD as a novel predictor of lymph node metastasis and prognosis in solid tumors: a systematic review and meta-analysis. Technol Cancer Res Treat. 2020;19:153303382096358.
  • Gao W, Weng T, Wang L, et al. Long non-coding RNA NORAD promotes cell proliferation and glycolysis in non-small cell lung cancer by acting as a sponge for miR-136-5p. Mol Med Rep. 2019;19(6):5397–5405.
  • Zhao W, Wang L, Xu F. LncRNA NORAD stimulates proliferation and migration of renal cancer via activating the miR-144-3p/MYCN axis. Eur Rev Med Pharmacol Sci. 2020;24(20):10426–10432.
  • Kurniawan DW, Storm G, Prakash J, et al. Role of spleen tyrosine kinase in liver diseases. World J Gastroenterol. 2020;26(10):1005–1019.
  • Yang P, Niu Y. TGF-β1/Smad signaling pathway in tissue fibrosis:research advances. Int J Pharm Res. 2019;46(10):7.
  • Meng X-M, Tang PM-K, Li J, et al. TGF-beta/Smad signaling in renal fibrosis. Front Physiol. 2015;6:82.
  • Aristizábal JF, Ríos H, Rey D, et al. Interleukin 1-beta (IL-1β) polymorphism and orthodontics: a systematic review. Rev Fac Odontol Univ Antioq. 2019;31(1–2):147–161.
  • Singh S, Anshita D, Ravichandiran V. MCP-1: function, regulation, and involvement in disease. Int Immunopharmacol. 2021;101(Pt B):107598.
  • Rose-John S. Interleukin-6 signalling in health and disease. F1000Res. 2020;9:1013.
  • Subedi L, Lee SE, Madiha S, et al. Phytochemicals against TNF alpha-mediated neuroinflammatory diseases. IJMS. 2020;21(3):764.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.